Chembio Diagnostics
CEMI
$0.46
Share price
0.22%
Change (1 day)
-56.25%
Change (1 year)
Categories
P/S ratio for Chembio Diagnostics (CEMI)
P/S ratio as of April 2024 (TTM): 0.3457
According to Chembio Diagnostics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.345683. At the end of 2022 the company had a P/S ratio of 0.1668.
P/S ratio history for Chembio Diagnostics from 2004 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 0.1668 | -82.01% |
| 2021 | 0.9276 | -70.54% |
| 2020 | 3.15 | 34.17% |
| 2019 | 2.35 | -19.32% |
| 2018 | 2.91 | -30.86% |
| 2017 | 4.21 | -8.1% |
| 2016 | 4.58 | 116.32% |
| 2015 | 2.12 | 55.64% |
| 2014 | 1.36 | 27.82% |
| 2013 | 1.06 | -28.35% |
| 2012 | 1.48 | 8.21% |
| 2011 | 1.37 | -13.38% |
| 2010 | 1.58 | 26.23% |
| 2009 | 1.25 | 103.42% |
| 2008 | 0.6167 | -65.17% |
| 2007 | 1.77 | 3.41% |
| 2006 | 1.71 | 127.04% |
| 2005 | 0.7542 | -58.39% |
| 2004 | 1.81 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Trinity Biotech
TRIB | 0.2338 | -32.36% | 🇮🇪 Ireland |
 QuidelOrtho QDEL | 0.8536 | 146.92% | 🇺🇸 USA |
 OraSure Technologies OSUR | 0.9906 | 186.58% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 3.09 | 793.33% | 🇺🇸 USA |